I would not day trade this stock or any small biotech for that matter. do your due diligence, understand the opportunity and the risks and if you like the potential then I recommend buying in 25%-35% chunks. starting at these levels and dollar cost averaging in the $4s and $5s is a good bet since the expectations for the stock at between $15 and $25 in the next 12 months based on the continued development of plecanatide.
Well said. I agree that this stock will pop overnight once news breaks of SGYP entertaining or accepting an offer to sell ownership of its product and, or, company. The pop will be significant (in the triple digit %), so having a short position when this happens will be extremely painful, expensive and quick-with no time to react.
As of today, I have read nothing on this board that presents a fundamental reason to short this company, which is why I'm confident in holding my position. Rather, the available public information and reports indicates a solid reason to be long.